Evidence map›Paper›PMID 15923617›Full record

ArticleMolecular and cellular biology2005

CCT chaperonin complex is required for the biogenesis of functional Plk1.

Xiaoqi Liu, Chin-Yo Lin, Ming Lei, Shi Yan, Tianhua Zhou, Raymond L Erikson

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The TRiCky Business of Protein Folding in Health and Disease.Frontiers in cell and developmental biology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Folding for the Immune Synapse: CCT Chaperonin and the Cytoskeleton.Frontiers in cell and developmental biology · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma.International journal of clinical and experimental pathology · 2019
    Article
  17. Article
  18. Review
  19. Suppression ofOncology letters · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaoqi LiuDepartment of Molecular and Cellular Biology, Harvard University, 16 Divinity Ave., Cambridge, MA 02138, USA. liu13@fas.harvard.edu
Chin-Yo Lin
Ming Lei
Shi Yan
Tianhua Zhou
Raymond L Erikson
Harvard University · US

Funding

Polo-like Kinase Functions in Normal and Tumor CellsR01GM059172 · NIGMS · HARVARD UNIVERSITY · PI ERIKSON, RAYMOND L · 2000 to 2007
$3.4M
NIGMS NIH HHS GM59172NIGMS NIH HHS R01 GM059172
6 · The paper itself

Abstract

Experiments from several different organisms have demonstrated that polo-like kinases are involved in many aspects of mitosis and cytokinesis. Here, we provide evidence to show that Plk1 associates with chaperonin-containing TCP1 complex (CCT) both in vitro and in vivo. Silencing of CCT by use of RNA interference (RNAi) in mammalian cells inhibits cell proliferation, decreases cell viability, causes cell cycle arrest with 4N DNA content, and leads to apoptosis. Depletion of CCT in well-synchronized HeLa cells causes cell cycle arrest at G(2), as demonstrated by a low mitotic index and Cdc2 activity. Complete depletion of Plk1 in well-synchronized cells also leads to G(2) block, suggesting that misfolded Plk1 might be responsible for the failure of CCT-depleted cells to enter mitosis. Moreover, partial depletion of CCT or Plk1 leads to mitotic arrest. Finally, the CCT-depleted cells reenter the cell cycle upon reintroduction of the purified constitutively active form of Plk1, indicating that Plk1 might be a CCT substrate.

Indexed as

AnimalsApoptosisCdc20 ProteinsCell CycleCell Cycle ProteinsChaperonin Containing TCP-1ChaperoninsHeLa CellsHumansPhenotypePolo-Like Kinase 1Protein KinasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsRecombinant Fusion ProteinsRNA, Small InterferingCDC20 protein, humanCdc20 ProteinsCell Cycle ProteinsChaperonin Containing TCP-1ChaperoninsPolo-Like Kinase 1Protein KinasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsRecombinant Fusion ProteinsRNA, Small InterferingTCP1 protein, human

Identifiers

PMID15923617
PMCPMC1140568
OpenAlexW2102113384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.